Literature DB >> 36267257

Successful Treatment of Delayed Localized Necrotizing Inflammatory Myositis After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine: A Case Report.

Jennifer Chen Li1,2, Jonathan Siglin2,3, Michael S Marshall2,4, Anat Stemmer-Rachamimov2,4, Seth M Bloom2,5,6, Kimberly G Blumenthal1,2,7.   

Abstract

Reported adverse reactions to the mRNA-1273 vaccine (Spikevax, Moderna Inc) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) range from mild, local delayed cutaneous reactions to rarer, more serious reactions such as myocarditis. Here, we describe the presentation and successful treatment of delayed, localized necrotizing inflammatory myositis following a third dose of the mRNA-1273 SARS-CoV-2 vaccine. To our knowledge, this is the first report of biopsy-confirmed, delayed inflammatory myositis after administration of an mRNA-1273 SARS-CoV-2 vaccine booster.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; mRNA vaccine; myositis

Year:  2022        PMID： 36267257      PMCID： PMC9578160          DOI： 10.1093/ofid/ofac499

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN： 2328-8957            Impact factor:   4.423


  20 in total

1.  Cellulitis at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Authors:  Scott Halperin; Katrin S Kohl; Jane Gidudu; Leslie Ball; Sandra Jo Hammer; Paul Heath; Renald Hennig; Jerry Labadie; Edward Rothstein; Anne Schuind; Frederick Varricchio; Wikke Walop
Journal:  Vaccine       Date:  2007-05-11       Impact factor: 3.641

2.  Case Reports: Rhabdomyolysis Associated with COVID-19.

Authors:  Balraj Singh; Parminder Kaur; Ro-Jay Romor Reid
Journal:  Am Fam Physician       Date:  2020-12-01       Impact factor: 3.292

3.  Myocarditis and Pericarditis After Vaccination for COVID-19.

Authors:  George A Diaz; Guilford T Parsons; Sara K Gering; Audrey R Meier; Ian V Hutchinson; Ari Robicsek
Journal:  JAMA       Date:  2021-09-28       Impact factor: 56.272

4.  Rhabdomyolysis as the main manifestation of coronavirus disease 2019.

Authors:  S Rivas-García; J Bernal; J Bachiller-Corral
Journal:  Rheumatology (Oxford)       Date:  2020-08-01       Impact factor: 7.580

5.  Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.

Authors:  Kimberly G Blumenthal; Esther E Freeman; Rebecca R Saff; Lacey B Robinson; Anna R Wolfson; Ruth K Foreman; Dean Hashimoto; Aleena Banerji; Lily Li; Sara Anvari; Erica S Shenoy
Journal:  N Engl J Med       Date:  2021-03-03       Impact factor: 91.245

6.  COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis.

Authors:  Simon Faissner; Daniel Richter; Ulas Ceylan; Christiane Schneider-Gold; Ralf Gold
Journal:  J Neurol       Date:  2021-08-25       Impact factor: 4.849

7.  Clinicopathological Characteristics of Inflammatory Myositis Induced by COVID-19 Vaccine (Pfizer-BioNTech BNT162b2): A Case Report.

Authors:  Ji Hyoun Kim; Jun Hyoung Kim; Chang Gok Woo
Journal:  J Korean Med Sci       Date:  2022-03-21       Impact factor: 2.153

8.  Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died.

Authors:  Tom Aschman; Julia Schneider; Selina Greuel; Jenny Meinhardt; Simon Streit; Hans-Hilmar Goebel; Ivana Büttnerova; Sefer Elezkurtaj; Franziska Scheibe; Josefine Radke; Christian Meisel; Christian Drosten; Helena Radbruch; Frank L Heppner; Victor Max Corman; Werner Stenzel
Journal:  JAMA Neurol       Date:  2021-08-01       Impact factor: 18.302

9.  Inflammatory myositis after ChAdOx1 vaccination.

Authors:  Boby Varkey Maramattom; Geetha Philips; Joe Thomas; Shagos Gopalan Nair Santhamma
Journal:  Lancet Rheumatol       Date:  2021-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.